科学图书馆
-
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel studyB Schnorbus, A Daiber, T Gori et al. -
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
A randomised trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trialRampat R, Mayo T, Hildick-Smith D et al.
-
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry dataGA Figtree, ST Vernon, N Hadziosmanovic et al.
-
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesSchüpke S, Neumann FJ, ISAR-REACT 5 Trial Investigators.
-
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarctionKwong RY, Sattar H, Wu H et al.
-
Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological TechnologiesG Gallone, L Baldetti, G Tzanis et al.
-
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE TrialHenriques JP, Hoebers LP, EXPLORE Trial Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
